Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
News
Medicare Prescriptions for Wegovy Jumped After Approval for Heart Disease
Featured Experts: Dima M. Qato, Christopher Scannell, John Romley, Rebecca Myerson, Dana Goldman
In The News View All
Pink Sheet
Chen warns MFN could have unintended consequences and highlights need for US value-based pricing
Featured Experts: Alice Chen
MinnPost
Mulligan explains how 340B program encourages hospitals to favor more expensive drugs
Featured Experts: Karen Mulligan
Bloomberg
Lakdawalla explains why MFN could hold back new treatments in Europe
Featured Experts: Darius Lakdawalla
Financial Times
Medicare’s plan to speed up coverage of new medical devices may expand access to innovation, Padula says
Featured Experts: William Padula
The Washington Post
Padula outlines possible factors driving a recent decline in prescription drug costs
Featured Experts: William Padula
Featured Perspective
A Missed Chance to Make America Healthier and Richer
Medicare should revisit its decision not to broadly cover anti-obesity medications, considering the enormous value expanded access would generate for society.
Experts: Alison Sexton Ward, Dana Goldman
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
